For horses with navicular syndrome symptoms, Osphos Injection is a viable therapy option. When provided, this medicine will decrease illness development while providing relief. It comes in an easy-to-administer, ready-to-use formula.
Who is Osphos Inj 60mg/mL, 15 ml for?
Horses at least 4 years of age or older.
Why use Osphos Inj 60mg/mL, 15 ml?
This solution contains bisphosphonate and is only available as an intramuscular injectable option for the treatment of navicular syndrome symptoms. When this substance is given to the body, it functions to prevent bone resorption by adhering to calcium phosphate crystals and directly targeting osteoclast cells. It is a suitable alternative for horses with documented bone alterations since it contains 60mg clodronate per mL.
How does Osphos Inj 60mg/mL, 15 ml work?
This medication is used to treat navicular syndrome, which causes bone growth and breakdown. By adhering to calcium phosphate crystals and targeting osteoclast cells, the main ingredient directly targets bone resorption.
Dechra Pharmaceuticals
Osphos intramuscular injection contains the bisphosphonate Clodronic acid
How is Osphos Inj 60mg/mL, 15 ml sold?
Osphos Inj 60mg/mL is sold in 15ml - single use vial
What are the side effects of Osphos Inj 60mg/mL, 15 ml?
Colic, pawing, cramps, anxiety, and pain are the most prevalent adverse effects (which start within 2 hours of dosing), according to field research. After walking the horse for 10 to 15 minutes by hand, 8 out of 10 of the horses with these symptoms saw their clinical indications disappear. With no hand walking, one horse showed symptom alleviation. One was given medication for colic. Hives occurred in that horse as well, but he healed after being treated with dexamethasone and flunixin.
What special precautions are there?
Keep this product out of the reach of children.
If overdose occurs, please contact your local pet hospital or emergency pet clinic immediately.
How can I store Osphos Inj 60mg/mL, 15 ml?
Keep product stored in a dry and cool environment.
This is an intramuscular injection that is typically given at 1.8 mg per kilo. You should give the injection into 3 different areas. After the injection, you should throw away any unused content. The single-use vial doesn't have preservatives, so you should throw it away after you open it. If the horse doesn't get better right away, you should seek a reevaluation. There might be times when a horse gets better for a while and then gets worse again after 6 months.
OSPHOS should be re-administered once clinical symptoms reappear in horses that react to OSPHOS and maintain clinical recovery for 6 months. OSPHOS may be re-administered at 3 to 6 month intervals based on return of clinical symptoms in horses that first react to OSPHOS but do not sustain their clinical improvement for 6 months. If the horse does not respond to the initial therapy, it should be assessed again. OSPHOS is packaged in a single-use vial and is free of preservatives. Discard any remaining vial contents. OSPHOS is given intramuscularly at a rate of 1.8 mg/kg up to a maximum dosage of 900 mg per horse (one vial). Divide the whole volume into three injection sites equally.
Osphos intramuscular injection contains the bisphosphonate Clodronic acid